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Myc proteins are known to have an important function in
stem cell maintenance. As Myc has been shown earlier to
regulate microRNAs (miRNAs) involved in proliferation,
we sought to determine whether c-Myc also affects
embryonic stem (ES) cell maintenance and differentiation
through miRNAs. Using a quantitative primer-extension
PCR assay we identiﬁed miRNAs, including, miR-141, miR-
200, and miR-429 whose expression is regulated by c-Myc
in ES cells, but not in the differentiated and tumourigenic
derivatives of ES cells. Chromatin immunoprecipitation
analyses indicate that in ES cells c-Myc binds proximal
to genomic regions encoding the induced miRNAs. We
used expression proﬁling and seed homology to identify
genes speciﬁcally downregulated both by these miRNAs
and by c-Myc. We further show that the introduction of
c-Myc-induced miRNAs into murine ES cells signiﬁcantly
attenuates the downregulation of pluripotency markers on
induction of differentiation after withdrawal of the ES cell
maintenance factor LIF. In contrast, knockdown of the
endogenous miRNAs accelerate differentiation. Our data
show that in ES cells c-Myc acts, in part, through a subset
of miRNAs to attenuate differentiation.
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Introduction
MicroRNAs (miRNAs), 21–23 nucleotide non-protein coding
RNAs, act as powerful regulators of gene expression at
the post-transcriptional level by targeting speciﬁc mRNA
degradation or by suppression or activation of translation
(Carrington and Ambros, 2003; Dykxhoorn et al, 2003;
Grewal and Moazed, 2003; Pickford and Cogoni, 2003;
Vasudevan et al, 2007). Studies from many laboratories
have showed that miRNAs inﬂuence a wide range of biolo-
gical processes including development, lifespan, metabolism,
and cancer (Kato and Slack, 2008; Stefani and Slack, 2008).
Regulation of miRNA genesis occurs at multiple levels in
response to differentiation and mitogenic signalling (Thomson
et al, 2006; Viswanathan et al, 2008). Some miRNAs are
characteristic of speciﬁc differentiated cell types, whereas
others are speciﬁcally expressed in stem and progenitor cells
during early development (Lim et al, 2003; Chen et al, 2004;
Poy et al, 2004; Chang and Mendell, 2007; Hwang and
Mendell, 2007; Ibarra et al, 2007). Recent evidence has
shown that miRNA mutations or deregulations correlate with
different human cancers, and has also shown that miRNAs
can function as tumour suppressors or oncogenes (Calin and
Croce, 2006; Esquela-Kerscher and Slack, 2006; Medina and
Slack, 2008; Tavazoie et al, 2008). The most well-characterized
miRNA cluster involved in tumourigenesis, miR-17-92, was
found to be induced by Myc oncoprotein expression (He et al,
2005; Mendell, 2005; O’Donnell et al, 2005).
The Myc protein family comprises basic helix-loop-helix-
zipper (bHLHZ) transcription factors (c-, N-, and L-Myc) that
can each form obligate heterodimers with the small bHLHZ
protein Max. Myc–Max heterodimers bind the E-box se-
quence CACGTG in many different cell types and activate
transcription of a large number of genes, many of which are
associated with cell growth. In addition, Myc has been
implicated in transcriptional repression of many genes that
normally limit cell-cycle progression (Adhikary and Eilers,
2005; Cole and Nikiforov, 2006; Kleine-Kohlbrecher et al,
2006). Myc’s broad effects on both normal and abnormal
cell behaviour have been generally assumed to relate to its
regulation of RNA polymerase II transcription of protein
coding target genes as well as RNA polymerase I and RNA
polymerase III transcription of RNAs involved in translation
and growth (Gomez-Roman et al, 2003; Arabi et al, 2005;
Grandori et al, 2005). However, the demonstration that Myc
also controls expression of a subset of miRNAs has added
another class of critical Myc targets. Induced expression of
c-Myc in the P493-6 B cell line showed upregulation of six
miRNAs within the miR-17 cluster on chromosome 13
through direct binding of Myc to the miR-17 locus (He et al,
2005; O’Donnell et al, 2005). Recently, Myc was shown to be
involved in repression of numerous miRNAs in tumour cell
lines, including the let-7 tumour suppressor, which regulates
expression of c-myc itself (Sampson et al, 2007; Chang et al,
2008) and miR-23a/b resulting in increased glutamine cata-
bolism (Gao et al, 2009). Thus, Myc proteins seem to be
intimately involved in the regulation of a broad range of
miRNAs, many of which are likely to have key roles in cell
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3157proliferation and cancer (for reviews see Lotterman et al,
2008; Medina and Slack, 2008).
Another biological setting in which Myc and miRNA
regulation may converge is in stem cell self-renewal and
pluripotency. Genetic studies in mice indicate that c-Myc is
involved in the growth, proliferation, and differentiation of
epidermal, neural and lung stem/progenitor cells, and hae-
matopoietic stem cells (Arnold and Watt, 2001; Knoepﬂer
et al, 2002; Okubo et al, 2005; Dubois et al, 2008). In
embryonic stem (ES) cells c-Myc has been shown to be
required for the maintenance of self-renewal whereas Myc
downregulation on withdrawal of leukaemia inhibitory factor
(LIF) is critical for differentiation (Cartwright et al, 2005).
Furthermore, myc family genes, together with Oct4, Klf4, and
Sox2, act to reprogramme differentiated cells into induced
pluripotent stem (iPS) cells with ES cell properties, suggest-
ing that c-Myc is a driver of pluripotency (Takahashi et al,
2007; Wernig et al, 2007). Although iPS conversion can occur
without introduction of Myc, the overall yield of converted
cells is dramatically decreased, as is the rate of conversion
(Nakagawa et al, 2008). miRNAs have also been implicated
in the ES cell function. Targeted deletion of the Dicer pre-
miRNA processing ribonuclease abrogated ES cell differ-
entiation whereas self-renewal was less drastically reduced
(Kanellopoulou et al, 2005; Murchison et al, 2005). Indeed,
a characteristic miRNA proﬁle has been deﬁned in murine
and human ES cell lines, which overlaps with miRNAs
implicated earlier in proliferation and tumourigenesis (Suh
et al, 2004; Calabrese et al, 2007). Moreover, two studies have
shown that pluripotency-related transcription factors regulate
many miRNAs and are themselves subject to miRNA regula-
tion (Marson et al, 2008; Tay et al, 2008). Furthermore, recent
reports show that ES cell-speciﬁc miRNAs belonging to the
miR-290 family promote the G1-S transition and self-renewal
in ES cells as well as induced pluripotency during reprogram-
ming of ﬁbroblasts (Wang et al, 2008; Judson et al, 2009).
These ﬁndings prompted us to determine whether c-Myc
might contribute to ES cell pluripotency through regulation
of miRNAs.
Results
Identiﬁcation of c-Myc-induced miRNAs in ES cells
To identify ES-speciﬁc c-Myc-induced miRNAs, we analysed
three cell populations that permit us to compare ES cells to
their differentiated and tumourigenic derivatives: (i) murine
AK7 ES cells (ii) induced haematopoietic stem/progenitor
cells (HSPs) derived from these ES cells on differentiation,
and (iii) tumours from mice transplanted with ES cell-derived
HSPs (Figure 1A). To determine the effects of increasing c-
Myc levels, we used a c-myc-expressing lentiviral vector in ES
cells (hereafter referred to as c-Mycþ cells) and identiﬁed
c-Myc-induced miRNAs after normalization to a lentiviral
vector control. We observed an 8–14-fold increase in c-myc
RNA and protein levels as determined by qRT–PCR and
immunoblotting, respectively (Supplementary Figure S1).
We also generated differentiated cells from control and
c-Mycþ ES cells. Treatment of murine ES cells with the
cytokines IL-3, IL-6, and SCF resulted in induction of HSPs
(Kushida et al, 2001; Burt et al, 2004). Finally, mixed T- and B-
cell tumours were collected from irradiated mice transplanted
with cytokine-induced c-Mycþ HSPs and compared with
vector control transplanted HSPs in the miRNA proﬁling
experiment (Supplementary Figure S2).
miRNA expression levels were measured using a quantita-
tive primer-extension PCR assay as described earlier
(Raymond et al, 2005; He et al, 2007). Primers representing
192 miRNAs were used in this study. To determine the effects
of increasing c-Myc levels we calculated the fold change in
miRNA copy number as the error-weighted average of the
ratio in Mycþ cells relative to the lentiviral vector control
(see Materials and methods). Figure 1B shows a heat map of
the most signiﬁcantly changed miRNAs in c-Mycþ versus
vector controls in the ES cell-derived populations as de-
scribed above. The ﬁgure displays results for two HSP, and
four tumour cell isolates independently derived from the
same ES cell line. Consistent with earlier ﬁndings (Mendell,
2005; O’Donnell et al, 2005), a subset of the oncogenic
miRNA cluster, miR17-92, was highly induced in c-Mycþ
differentiated cells, and in tumours from mice transplanted
with c-Mycþ HSPs derived from our Mycþ ES cells
(Figure 1B). However, the levels of these miRNAs were not
substantially altered in c-Mycþ ES cells. We also identiﬁed
four miRNAs, let-7, miR-29, miR-181, and miR-199 that are
decreased in c-Mycþ ES cells relative to the vector control.
Let-7 and miR-29 are downregulated by c-Myc in B-cell
lymphomas (Chang et al, 2008). In addition, we ﬁnd that
miR-181A and miR-181B are sharply induced in Mycþ differ-
entiated and tumour cells (Figure 1B). We also identiﬁed
several miRNAs, miR-124, miR-135A, miR-135B, miR-141,
miR-200, miR-302, miR-338, and miR-429 that seem to be
upregulated speciﬁcally by c-Myc in ES cells (induced Bfour-
fold in c-Mycþ cells; Figure 1B; see Supplementary Table S1
for complete list; Supplementary Figure S3A for northern
blots). These miRNAs are induced by c-Myc in ES cells, but
are either not increased or are strongly reduced in differen-
tiated haematopoietic cells (Figure 1B; Supplementary Figure
S3B) or in the tumours from transplanted mice. To further
examine the regulation of these miRNAs by c-Myc we
knocked down c-Myc levels two to four-fold in wild-type ES
cells using lentiviral shRNA (Supplementary Figure S1B) and
determined miRNA levels by quantitative primer-extension
PCR as described. Our results show that after Myc knock-
down the levels of miR-124, miR-135A, miR-135B, miR-141,
miR-200, miR-302, miR-338, and miR-429 are sharply reduced
(Figure 1B, compare top and bottom rows). The c-Myc knock-
down experiment also conﬁrms that expression of the miR17-
92 cluster is diminished in shMyc-treated ES cells compared
to the Mycþ differentiated and tumour cells, whereas
miRNAs repressed in Mycþ ES cells are strongly activated
after c-Myc knockdown (Figure 1B). Together, our data con-
ﬁrm that Myc activates or represses multiple miRNAs and
identiﬁes a subset of those whose speciﬁc expression in ES
cells is Myc dependent.
Earlier studies had reported that among the group of c-
Myc-regulated miRNAs in ES cells described above, miR-135
and miR-124 regulate neurogenesis during central nervous
system (CNS) development (Cao et al, 2007; Visvanathan
et al, 2007). miR-302 is related to the miR-290 family several
of whom have been recently shown to promote ES cell
proliferation by targeting cell-cycle regulators (Wang et al,
2008). Interestingly, miR-291-3p, -294, and -295 seem to be
directly regulated by Myc during reprogramming of ﬁbro-
blasts to induce pluripotency (Judson et al, 2009). However,
Myc-induced microRNAs in embryonic stem cells
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such as miR-141, miR-200, miR-338, and miR-429 in ES cells,
have not been established. These miRNAs are endogenously
expressed in ES cells in a Myc-dependent manner and their
levels are augmented on c-Myc overexpression (Figure 1B;
Supplementary Figure S3A and B). We therefore chose to
focus on identifying targets and functions of these miRNAs.
Analysis of c-Myc binding to selected miRNA loci
To address whether c-Myc might regulate these miRNAs by
direct binding to their genomic loci, we mapped the genomic-
binding sites of c-Myc in ES cells using DNA derived from
anti-c-Myc chromatin immunoprecipitation (ChIP) to probe a
custom-designed DNA microarray (chip) tiling 3Kb regions
of miR-124, miR-135, miR-141, miR-200, miR-302, miR-338,
and miR-429. Three independent sets of ChIPs with c-Myc
antibody versus input DNA were hybridized to the custom
array. The enrichment ratio for ChIP/input DNA (Figure 2A,
grey dots, plotted on a log2 scale in which dotted purple line
indicates log2¼1) and the statistics program Algorithm for
Capturing Microarray Enrichment (ACME) (Scacheri et al,
2006b) were used to identify chromosomal regions with
statistically signiﬁcant c-Myc binding (Figure 2A, red lines,
see Material and methods section for details). Figure 2 shows
binding by endogenous c-Myc proximal (within 100–200bp)
to coding regions for miR141, miR200/miR429, miR338.
When we applied the ChIP–chip analysis to c-Mycþ ES
cells we detected signiﬁcant binding and/or additional bind-
ing sites at the miR-141, miR-200, miR-338 loci (Figure 2A).
We also observed little or no endogenous c-Myc binding
to either miR124 or miR135a whereas increased Myc
levels generates binding in the vicinity of these two miR
transcripts (Supplementary Figure S4). Interestingly, neither
endogenous nor overexpressed c-Myc binds to the miR302
locus (Supplementary Figure S4), suggesting c-Myc indirectly
induces miR302. We further validated the binding of Myc
to genomic loci proximal to miR-141, miR-200, miR-338, and
miR429 by qChIP–PCR using primers to amplify the bound
regions deﬁned by our array analysis (Figure 2B). Myc
binding to miRNA loci occurred to the same extent as
endogenous binding to the Myc target gene HirA (Chen
et al, 2008; Kim et al, 2008). Evx2 served as a negative
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Figure 1 miRNAs regulated by c-Myc in murine ES cells. (A) Scheme showing the experimental design for identiﬁcation of miRNAs regulated
by c-Myc in ES cells. c-Myc level was increased by lentiviral-delivered overexpression of c-Myc in ES cells (see Supplementary Figure S1).
These ES cells, their differentiated haematopoietic stem/progenitor cell derivatives (HSP Mycþ) and tumours after injection of HSP c-Mycþ
cells into irradiated mice, were subjected to miRNA proﬁling. (B) Heatmap of miRNAs displaying signiﬁcant regulation by c-Myc in ES cells and
ES cell-derived differentiated cells or tumours. HSP: haematopoietic stem/progenitor cells derived by differentiation of ES cells; Tumours1–4:
mixed T- and B-cell tumours derived by transplantation of Mycþ HSPs into irradiated mice. Note that results are shown for two HSP, and four
tumour cell isolates independently derived from the same ES cell line. Bottom row shows miRNAs levels after c-Myc knockdown in WT ES
cells. Inset: Fold change in miRNA copy number represents the ratio of miRNA level in ES cell in which c-Myc has been introduced (Mycþ), or
knocked down by c-myc shRNA (ES Myc KD), relative to lentiviral vector (see Supplementary Figure S1 for quantitation). Grey boxes represent
no detectable signal.
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c-Myc binding to the same miRNA loci in HSPs (data
not shown), consistent with our data showing that these
miRNAs are not induced by Myc in these differentiated cells
(Figure 1B; Supplementary Figure S3B).
Analysis of the targets of ES-speciﬁc c-Myc-induced
miRNAs
RNAs targeted by miRNAs are generally degraded and can be
identiﬁed through expression array analysis (Lim et al, 2005;
Visvanathan et al, 2007; Liu et al, 2008; Ziegelbauer et al,
2009). Therefore, to assess the extent to which miR-141, miR-
200a, miR-429, miR-338-3p, and miR-302a control gene ex-
pression in ES cells, we used expression array proﬁling to
identify transcripts regulated by each miRNA. An RNA duplex
was designed for each miRNA in which the guide (active)
strand matches the mature form of the natural miRNA
(see Supplementary Table S2 for sequences). This approach
has been used extensively to identify and conﬁrm miRNA
targets (Lim et al, 2005; Visvanathan et al, 2007). Duplexes
were transfected into ES cells, and RNA was collected 12
or 24h later. The miRNA-regulated genes were identiﬁed
using oligonucleotide microarrays representing 21000 genes.
Transcripts regulated by the miRNA were identiﬁed as those
whose expression was signiﬁcantly decreased with a P-value
p0.01 relative to mock-transfected cells (see Materials and
methods). Two independent experiments were performed,
one including both 12 and 24h time points after transfection,
and one analysing a 24h time point. The 12h sample was
included as an early time point to show trends in kinetic
regulation of transcripts and aid in identiﬁcation of direct
targets. Figure 3 shows a heat map for transcripts regulated
by miR-141, miR-200, miR-302, miR-338, and miR-429. We
observed good agreement among the transcripts regulated in
the individual 24h samples by miR-141 and miR-200. The
duplexes corresponding to miR-141 and miR-200 had over-
lapping but non-identical seed regions (see Supplementary
Table S2 for sequences). Consistent with this, the signatures
for these miRNAs were partially overlapping, that is some
transcripts were regulated in common by both miRNAs,
whereas some transcripts were regulated only by the indivi-
dual miRNAs. miR-429, with a seed region unrelated to miR-
141 or miR-200, regulated an independent set of transcripts.
The transcripts showing signiﬁcant downregulation for each
miRNAwere enriched in 30 UTR sequences complementary to
the seed region of the transfected miRNA (Figure 3). The
signatures for each miRNA target set showed enrichment for
all three hexamers corresponding to the seed region of
that miRNA. Hexamer enrichment ranged from an E-value
(P-value with Bonferroni correction) of 10
 2–10
 13. Thus, the
microarray analysis identiﬁed transcripts likely to be direct
targets of the miRNAs. Similar data were obtained for miR-
338 and miR-302 (see Supplementary Table S3).
We reasoned that if the miRNAs identiﬁed here are part of
a c-Myc-regulated pathway in ES cells, then the transcripts
downregulated by the miRNAs should overlap with tran-
scripts downregulated by c-Myc overexpression. We therefore
looked for genes whose expression is downregulated by both
miRNA transfection and in response to c-Myc overexpression
(Figure 4). Myc-regulated genes in ES cells were identiﬁed
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Figure 2 Association of c-Myc with genomic regions proximal to miRNA genes. (A) c-Myc genomic binding was assessed by ChIP–chip
analysis. ACME statistical analysis (–log10 P-value scale on left side of each panel), plotted as red dots, indicates statistically signiﬁcant
enrichment. The ACME data are derived from the fold enrichment ratios (log2 scale on the right side of each panel) representing the ChIP
enriched versus total input genomic DNA for all probes within the indicated genomic regions and plotted as grey dots. x axis represents the
genomic region surrounding the miRNA loci with tiling oligonucleotide probes on a custom-designed tiling array. Positions of the mature
miRNA transcripts are indicated by green or orange bars. Arrows indicate direction of transcription. (B) c-Myc binding at microRNA loci.
qChIP–PCR was carried out as described in Materials and methods using AK7 mES cells. Shown is endogenous c-Myc binding to the known
c-Myc target gene HirA as a positive control. The Evx2 locus was used as a negative control. Analysis of Myc binding to the indicated miRNA
genomic loci was carried out using ChIP from wild-type ES cells (endogenous) as well as ES cells overexpressing c-Myc (overexpression).
Equal amounts of anti-c-Myc ChIP DNA and total input DNA were used for quantitative PCR using SYBR Green detection with an ABI7900HT
system. The sequences of all primers for qChIP–PCR were based on the Myc-binding sites (100–200bp from microRNA coding regions)
identiﬁed from ChIP–chip analysis and are available on request. Bar heights represent the Myc-bound DNA as a percentage of the total input
DNA as determined from four independent sets of experiments.
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above. Approximately one-third of the targets for each miRNA
overlapped with c-Myc-regulated transcripts (Figure 4). As a
control we examined miR-382, an miRNA that has not been
found to be regulated by c-Myc, and determined that only 2
of 65 miR-382 repressed targets overlap with genes down-
regulated by c-Myc, a number lacking statistical signiﬁcance
(P¼0.12) (Figure 4).
Among the genes signiﬁcantly repressed by both c-Myc
and the c-Myc-induced miRNAs, a subset has been implicated
in growth arrest and differentiation of a number of cell types
(Supplementary Table S3; see Discussion). To validate the
expression proﬁling results, we employed qRT–PCR to assess
expression of 20 potential targets 24h after transfection
of duplex miRNAs into ES cells (Figure 5A). We conﬁrmed
by northern blotting that the levels of introduced miRNAs
are comparable to those following induction by c-Myc
(see Supplementary Figure S5). Our results show that intro-
duction of these miRNAs into ES cells is associated with
decreased transcript levels for the predicted miRNA targets.
Furthermore, using immunoblotting we found that the pro-
tein levels of several target genes, such as amphiregulin
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Figure 3 Expression proﬁling identiﬁes putative targets of c-Myc-induced miRNAs. Heatmap of transcript levels after transfection of ES cells
with miR-141, miR-200, miR-338, miR-302, or miR-429. ES cell RNA was hybridized to Agilent microarrays containing oligonucleotides
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receptor 3 (Tgfbr3), were sharply decreased at 48h after
miRNA transfection (Figure 5B).
To determine whether miRNA target downregulation is
mediated through recognition of the miRNA seed sequences,
we cloned 30 UTRs from Cdh11, Nrp1, and the zinc-ﬁnger
homeobox gene (Zfh1a), which are target genes of miR-141,
miR-200, and miR-429, respectively (Figure 5C). These 30
UTRs contain seed homology sequences speciﬁc for each
miRNA. We next made point mutations by site-directed
mutagenesis within the 30 UTR seed homology elements to
test the miRNA target site speciﬁcity. We generated reporter
constructs containing the wild type and mutant target 30 UTR
sequences linked to luciferase. The wild type or mutant
reporters were co-transfected with individual miRNA
duplexes into HeLa cells. Data were normalized to a co-
transfected Renilla luciferase (RL) control. Figure 5C shows
that miR-141, miR-200, and miR-429 speciﬁcally inhibit activ-
ity from their cognate wildt-ype reporter genes whereas
mutagenesis of the miRNA recognition sites abolishes the
inhibition by these miRNAs.
As a further test of speciﬁcity we determined the effect of
each miRNA duplex on endogenous Cdh11, Nrp1, and Zfh1a
RNA levels by qRT–PCR (Supplementary Figure S6). We
compared miRNA duplexes with wild-type and scrambled
seed regions (Supplementary Figure S6A). In each case,
downregulation of the speciﬁc target gene for a given
miRNA is dependent on the miRNA having an intact seed
region homologous to the target gene 30 UTR. We also
used LNA-anti-miRNAs (see below) along with scrambled
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Figure 5 Target gene speciﬁcity of Myc-induced miRNAs. (A) The transcript levels of the indicated microRNA targets were validated by real-
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mock control (DDCt). Error bars show standard error of the mean. (B) Total protein extracted from ES cells 48h post transfection of miRNA
duplexes was analysed by immunoblotting with commercially available antibodies. Mock-transfected cells were used as controls and g-tubulin
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Supplementary Figure S6B, upregulation of RNA expression
of the endogenous target gene is dependent on a wild-type
seed region. We further extended these experiments by
examining target gene protein levels. After introduction of
c-Myc into ES cells we observe decreased levels of Nrp1,
Cdh11, and Areg proteins, as determined by immunoblotting
(Supplementary Figure S6C). However, treatment of the
c-Myc-overexpressing cells with LNA-anti-miRNAs, directed
against the endogenous Myc-induced miRNAs that speciﬁ-
cally target these gene products, results in upregulation of
their protein levels (Supplementary Figure S6C). Taken to-
gether, our transient reporter assays and determination of
endogenous target gene levels support the idea that regula-
tion of the miRNA target genes deﬁned by our expression
proﬁling experiments is speciﬁc and that Myc-mediated silen-
cing of at least a subset of these targets is dependent on Myc-
induced miRNAs.
c-Myc-induced miRNAs inﬂuence ES cell pluripotency
Our ﬁnding that c-Myc-regulated miRNAs miR-141, miR-200,
miR-338, and miR-429 are expressed in ES cells and that a
subset of their target genes is associated with lineage differ-
entiation raises the question of whether these miRNAs affect
the balance of ES self-renewal and differentiation. Addition of
LIF to the culture medium maintains ES cells in a self-
renewing pluripotent state whereas withdrawal of LIF is a
widely used method to induce ES cell differentiation (Solter
and Knowles, 1978; Houbaviy et al, 2003; Cartwright et al,
2005; Chen et al, 2007). LIF removal permits spontaneous,
non-biased differentiation into multiple cell types including
cardiac myocytes, striated skeletal muscle, neuronal cells,
and haematopoietic progenitors. In ES cells, LIF has been
shown to stimulate c-myc expression whereas c-Myc abun-
dance sharply decreases on LIF removal (Cartwright et al,
2005). To evaluate whether enforced expression of miR-141,
miR-200, miR-338, and miR-429 is involved in ES cell identity
we therefore tested the ability of ES cells transduced with
these miRNAs to differentiate subsequent to LIF withdrawal.
ES cell pluripotency was evaluated over time after LIF
removal (i) visually by staining for alkaline phosphatase
(AP) activity (Cartwright et al, 2005) (Figure 6A) as well as
by (ii) quantitative changes in the population of SSEA-1-
positive stem cells (Solter and Knowles, 1978) (Figure 6B).
The ﬂow cytometric measurements of SSEA represent 10000
gated cells for each time point. Figure 6A and B show
decreases in both AP and SSEA-1-positive staining in wild-
type mES cells between 2 and 10 days after LIF withdrawal
whereas parallel cultures maintained in LIF have no evident
change in these markers (see Figure 8B). The reduction in AP
and SSEA-1 staining is partially abrogated by the introduction
of wild-type c-Myc (Figure 6A, far right panel and Figure 6B).
Transduction of miRNAs miR-141, miR-200, and miR-429
each results in levels of AP staining over 5 and 10 days that
are well above those observed for mock-treated ES cells but
less than that detected in c-Mycþ ES cells (Figure 6A). In
parallel experiments, we tested miRNA duplexes with
scrambled seed regions and found these to be considerably
less effective than the wild-type miRNA duplexes in atten-
uating loss of AP staining (Supplementary Figure S7A).
Moreover, the percentage of SSEA-positive cells was signiﬁ-
cantly higher on transduction of these individual miRNAs
when compared with mock-transfected cells, although, again,
the effect was not as pronounced as with c-myc overexpres-
sion (Figure 6B). We also found that combining miRNAs-141,
-200, -338, and -429 (miR-mix) effectively attenuated loss of
AP staining on LIF withdrawal (Figure 6A and B). miR-338
and miR-302 were relatively ineffective in maintaining AP as
well as SSEA staining. It is important to note that the changes
in AP and SSEA are not because of alterations in cell
proliferation or cell numbers. After LIF removal, self-renewal
ceases and the individual colonies that lose AP staining retain
approximately the same number of cells (see Supplementary
Figure S7B). Furthermore, we have determined directly that
the Myc-induced miRNAs do not affect ES cell population
doubling time (Supplementary Figure S7C) or proliferation as
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Figure 6 c-Myc-induced miRNAs affect the balance between ES cell self-renewal and differentiation. ES cells were either mock transfected or
transfected with the indicated miRNAs and/or c-myc. Twenty-four hours after transfection, LIF was withdrawn from the medium. miR-mix
indicates transfection of a mixture of miR-141, -200, -338, -429. (A) Staining for alkaline phosphatase activity at the indicated times after LIF
elimination. A single well is shown for each time point. (B) Flow cytometric determination of SSEA-1 staining at the indicated times after LIF
elimination for ES cells into which miRNAs or constructs were introduced as indicated at right. The %SSEA indicates the fraction stained
relative to mES cells in the presence of LIF. 10000 gated cells were used for each dataset. *P-valueo0.05, **P-valueo0.01, ***P-value o0.001.
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2007) (data not shown).
We also examined expression of the pluripotency factor
Nanog by immunostaining after the introduction of the miR-
mix or c-Myc at 3 and 7 days after LIF removal (Figure 7A).
The miR-mix ES cultures show higher levels of Nanog than
mock-treated controls although the Nanog levels are highest
in the c-Myc-overexpressing cultures at day7 after LIF with-
drawal. To provide a more quantitative analysis, we used
immunoblotting with anti-Nanog and found that miR-mix
and c-Myc-overexpressing cells had approximately two-fold
and ﬁve-fold increased Nanog levels, respectively, compared
with mock controls (Figure 7B). Although Nanog expression
decreased makedly at day 10 after LIF withdrawal, the level
of Nanog is still highest in c-Myc-overexpressing cells
(Figure 7A, DAPI staining showed cells are present in the
image). Therefore, our assessment of ES cell markers, AP,
SSEA, and Nanog, indicates that the c-Myc-induced miRNAs
act to attenuate ES cell differentiation on LIF removal.
To further assess the speciﬁcity of the observed miRNA
biological activity we partially inhibited endogenous
miRNA activity in ES cells using locked-nucleic acid anti-
miRNAs (LNA-anti-miRNA; see Materials and methods).
Representative LNA-anti-miRNA knockdowns of the c-Myc-
induced miRNAs are shown in the northern blots in
Supplementary Figure S8. We had earlier shown the seed
speciﬁcity of these anti-miRNAs on several miRNA endo-
genous target genes (see Supplementary Figure S6) as well
as their ability to reverse Myc-induced target repression
(Supplementary Figure S6C). Introduction of LNA-anti-
miRNAs against individual or mixed c-Myc-induced
miRNAs resulted in a modest but signiﬁcant acceleration of
differentiation as measured by diminished SSEA and AP
activity relative to mock-treated cells, most strongly at
day 10 after LIF removal (Figure 7C; data not shown). We
detected markers for both neuronal (TUJ1) and muscle
(MF20) differentiation (data not shown) indicating that
differentiation occurs along multiple lineages. Our data
show that the overexpression of the c-Myc-induced miRNAs
has the opposite effect as the LNA-anti-miRNAs on SSEA
levels after LIF removal relative to the mock controls in each
experiment (compare Figures 6B and 7C).
An earlier study had shown that an oncogenically activat-
ing point mutation in c-myc led to ES cell self-renewal in the
absence of LIFand, further, that a putative dominant-negative
mutant of c-Myc inhibited self-renewal and promoted differ-
entiation (Cartwright et al, 2005). Here, we have used an
shRNA against c-myc to directly decrease c-Myc levels and
observed that reduction in c-Myc abundance enhances loss
of both SSEA and AP markers as well as ES cell colony
morphology after LIF withdrawal (Figure 8A and B;
Supplementary Figure S10) in general agreement with the
earlier study. We therefore assessed whether the c-Myc-
induced miRNAs affect the rate of differentiation after
c-myc knockdown. We introduced a mixture of miR-141,
miR-200, miR-338, and miR-429 into ES cells that were
treated with shRNA against c-myc. We then removed LIF
and assessed loss of pluripotency markers. We ﬁnd that the
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Figure 7 c-Myc-induced miRNAs affect the expression of pluripotency marker and differentiation. (A) Staining for the pluripotency marker
Nanog at days 3 and 7 after LIF elimination. Each image was taken from a single well. Staining of Nanog and DAPI at day 10 after LIF removal
shows cells within the wells are heterogeneous with respect to Nanog expression. Bar indicates 50mm. (B) Nuclear extracts from ES cells at 7
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Myc-induced microRNAs in embryonic stem cells
C-H Lin et al
The EMBO Journal VOL 28 | NO 20 | 2009 &2009 European Molecular Biology Organization 3164miRNAs reversed the loss of AP activity observed in c-myc
knockdown ES cells over a 10-day period after LIF withdrawal
(Figure 8B). Determination of SSEA staining at an inter-
mediate time point (day 7 after LIF removal) also shows
that an miRNA mixture, or miR-141 alone, signiﬁcantly
retards loss of the SSEA marker compared with mock-treated
c-myc knockdown ES cells (Figure 8C). Nanog levels were
also increased by the miR-mix as well as by individual
miRNAs (Supplementary Figure S9). Our results indicate that
co-transfection of Myc-induced miRNAs attenuates ES cells
differentiation under conditions of LIF removal and c-Myc
depletion.
Discussion
In this study we provide evidence that, in mES cells, intro-
duction of c-Myc induces miRNAs whose targets include
genes involved in differentiation. We focused on a subset of
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Figure 8 Myc-induced miRNAs attenuate differentiation of c-Myc-depleted ES cells on LIF withdrawal. (A) The percentage of cells staining
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expressing shRNA against c-myc (green bars). Data are expressed as the percentage of SSEA-1-positive mES cells in the absence of LIF relative
to mES cells in the presence of LIF. *P-valueo0.05, **P-valueo0.01, ***P-value o0.001. (B) mES cells were infected with empty lentiviral
vector (WT) or lentiviral vector expressing shRNA against c-myc. After selection, the c-Myc knockdown ES cells (see A above) were either
electroporated with a mixture of miRNAs (miR-141, -200, -338, -429) or electroporated without addition of miRNAs. Twenty-four hours after
transfection, LIF was withdrawn from the medium. Left panel shows WT ES cells maintained in LIF for the time course of the experiment.
A single well is shown for each time point. (C) SSEA-1 ﬂow cytometry 7 days after LIF withdrawal from c-myc knockdown ES cells transfected
as indicated in the inset. *P-valueo0.05, **P-valueo0.01, ***P-value o0.001.
Myc-induced microRNAs in embryonic stem cells
C-H Lin et al
&2009 European Molecular Biology Organization The EMBO Journal VOL 28 | NO 20 | 2009 3165these miRNAs that are upregulated by c-Myc in ES cells but
not in the differentiated and tumourigenic derivatives of
these ES cells, even though they continue to express ectopic
Myc. Although the levels of these miRNAs are increased by
Myc overexpression, they are nonetheless expressed endo-
genously in ES cells, and knockdown of endogenous c-Myc
reduces their expression.
We decided to concentrate on miR-141, miR-429, miR-200,
miR-338, and miR-302, a subset of the miRNAs identiﬁed in
our screen, as these had neither been characterized earlier
nor been linked to Myc function. We established that both
endogenous and overexpressed c-Myc protein binds to geno-
mic DNA in the vicinity of the coding sequences of all these
miRNAs with the exception of miR-302. However, we have
not been able to detect potential E-box-related Myc–Max-
binding sites associated with the Myc-bound regions, sug-
gesting that a non-canonical mode of Myc binding occurs at
these sites. E-box-independent Myc association with DNA has
been reported earlier (Eilers and Eisenman, 2008) and further
experiments will be required to delineate the nature of Myc
binding to these miRNA encoding regions. As the promoter
and regulatory regions of these miRNAs have not yet been
analysed, we cannot deﬁnitively determine whether such
binding by Myc directly results in transcriptional activation
of these miRNA genes. Nonetheless, the induction of these
miRNA genes by Myc, coupled with our ﬁnding of dosage-
dependent Myc binding near their coding regions provides
circumstantial evidence that they are directly targeted by
Myc. Moreover, we show, by means of expression proﬁling
using oligonucleotide microarrays, that gene sets downregu-
lated by our identiﬁed miRNAs (and that possess their
cognate seed-binding regions) display highly signiﬁcant
overlap with genes downregulated by c-Myc in mES cells.
The fact that this overlap is only partial may be because
of the inability of introduced c-Myc to maintain high
levels of these miRNAs attained after duplex transfection.
Furthermore, we show that the speciﬁc downregulation de-
pends on the seed sequences of the miRNAs and on the
miRNA response elements complementary to these seed
sequences that are located within the 30 UTRs of target
genes. Finally, we show that speciﬁc LNA-anti-miRNAs result
in seed-dependent upregulation of the cognate miRNA target
genes. Taken together, these data suggest that c-Myc down-
regulates the genes identiﬁed in the microarray analysis
through the c-Myc-induced mES cell-speciﬁc miRNAs we
have deﬁned here.
To determine whether the Myc–miRNA pathway is func-
tional in mES cells we assessed the effects of introducing
Myc-regulated miRNAs on ES cell differentiation. Importantly,
we show that overexpressed wild-type c-Myc itself delays
but does not completely block differentiation. Expression of
miR-141 and miR-429 and a mixture of miRNAs (comprising
miR-141, -200, -338, -429) were most effective in retarding
loss of AP activity, SSEA staining, and Nanog expression
in mES cells after LIF removal. In contrast, introduction
of the corresponding LNA-anti-miRNAs facilitated differ-
entiation. Moreover, knockdown of endogenous c-Myc
strongly accelerates differentiation, an effect that is signif-
icantly reversed by introduction of the miRNA mixture.
These data indicate that c-Myc levels control the rate of ES
cell differentiation and that c-Myc-regulated miRNAs can
function in this process. We note that in our experiments
the myc-induced miRNAs attenuated, but did not entirely
block, the loss of ES cell pluripotency markers. We surmise
that these miRNAs represent only a part of the process that
results in ES cell differentiation and act cooperatively or
redundantly with other factors. Indeed, we have found that
many of our miRNA target genes have been reported earlier
to be bound by Polycomb group proteins (C-HL and RNE,
unpublished). In addition, because of the limited nature of
our miRNA screen and the use of RNA expression proﬁling
rather than proteomics (which has not been effectively used
with ES cells) we have most likely not identiﬁed all Myc-
regulated miRNAs in ES cells.
One mechanism through which Myc-regulated miRNAs
can inﬂuence ES cell pluripotency and attenuate differentia-
tion is through the inhibition of differentiation-speciﬁc genes.
Among the c-Myc/miRNA targets we found that a subset has
been implicated in differentiation. These include the Tgfbr3
(miR-141 and miR-200) involved in multiple developmental
pathways, and Cdh11 (miR-141). Cdh11 is an adhesion mole-
cule that has an important role in developmental processes
such as morphogenesis and induction of neurite outgrowth
(Taniguchi et al, 2006; Boscher and Mege, 2008). Another
Myc and miRNA downregulated target is Nrp1 (miR-200 and
miR-338) a co-receptor for class 3 semaphorins with key roles
in axonal guidance. Nrp1 is essential for neuronal and
cardiovascular development and controls axon guidance
through neural crest cells (Mizui and Kikutani, 2008; Pellet-
Many et al, 2008; Schwarz et al, 2008). Interestingly, one of
the Nrp1 interacting semaphorins (Sema3a) is also targeted
by c-Myc through miR-200. Another overlapping target is
Foxf2, a mesenchymal factor that controls epithelial pro-
liferation and survival during murine gut development
(Ormestad et al, 2004, 2006). Foxf2 is also expressed in the
neural crest, CNS, and limb mesenchyme (Wang et al, 2003).
Importantly, in independent experiments we have conﬁrmed
that these and other Myc/miRNA targets are downregulated
at the protein and/or RNA level. Therefore, Myc-induced
miRNAs in ES cells may contribute to inhibition of broad
aspects of cell-type differentiation during development.
It has been suggested that ES cells have established a self-
organizing network to maintain self-renewal and pluripo-
tency (Bernstein et al, 2006; Boyer et al, 2006; Lee et al,
2006; Tay et al, 2008). Accumulating evidence indicates that
Myc family proteins may contribute to this network as they
are involved in the development of pluripotency and the
control of ES cell self-renewal and differentiation. A great
deal of earlier work has shown that differentiation-speciﬁc
genes in ES cells are repressed but maintained in a poised
state for transcriptional activation through the binding of
Polycomb complexes (Azuara et al, 2006; Bernstein et al,
2006; Boyer et al, 2006; Bracken et al, 2006; Lee et al, 2006).
The data presented in this paper show that at least a part of
Myc’s role in pluripotency lies in the inhibition of differentia-
tion-speciﬁc genes in ES cells through modulation of the
expression of a group of miRNAs (Figure 9). These miRNAs
may reinforce repression of Polycomb-bound genes as well as
act on an entirely different set of differentiation targets. In
conclusion, we have characterized subsets of miRNAs that are
regulated by c-Myc and are important in ES cell identity.
Further parsing of these miRNAs and their targets may provide
a means to drive ES cell differentiation along speciﬁc lineages
and to facilitate conversion of somatic cells into iPS cells.
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Cell culture
ES cell lines R1 and AK7 were cultured in DMEM supplied with
10%FBS, L-glutamine, non-essential amino acid, sodium pyruvate,
LIF, and b-mercaptoethanol. ES cells were thawed on plates with
mitomycin C-inactivated mouse embryonic ﬁbroblasts and then
grown and expanded on 0.1% gelatin-coated plates for subsequent
experiments.
Manipulating c-Myc level in ES cells by lentiviral-delivered
overexpression
c-Myc cDNA was ampliﬁed from an ES-derived cDNA library and
cloned into lentiviral vector pLenti6/V5-DEST (Invitrogen) for
overexpression. Lentiviral production followed an earlier published
protocol (Lois et al, 2002). Three days subsequent to viral infection
of ES cells blasticidin was used to select for cells with integrated
lentiviruses. Positive clones were picked and expanded for RNA
extraction and for miRNA and gene expression proﬁling experi-
ments. In parallel experiments, c-Mycþ ES cells were induced
along haematopoietic lineages using an earlier established protocol
(Burt et al, 2004) and then transplanted into irradiated (800cGy)
Balb/cJ mice and (1000cGy) C57/BL6 by intra-bone marrow
injection (Kushida et al, 2001). To identify ES-speciﬁc c-Myc-
induced miRNAs, RNA obtained from ES cells, induced haemato-
poietic cells, and tumours from transplanted mice were used for
miRNA proﬁling. This work was approved by FHCRC IACUC
protocol 1195.
Quantitation of miRNA levels
Quantitative PCR: miRNA levels were determined using a quanti-
tative primer-extension PCR assay (Raymond et al, 2005). Ct values
were converted to copy numbers by comparison to standard curves
generated using single-stranded mature miRNAs and are expressed
as copies/10pg (approximately equivalent to copies/cell). The fold
change in miRNA copy number was then calculated as the error-
weighted average of the ratio of c-Myc-overexpressing cells relative
to their corresponding empty lentiviral vector controls. miRNAs
showing copy numbers less than 1 or below the lower level of
detection for the miRNA assay were not used for further analysis.
For miRNA northern blotting, 20mg total RNA was applied on 12%
polyacrylamide (19:1)/8M urea/1 TBE gel. Subsequent to trans-
fer, the membrane was probed with g-P
32-ATP end labelled
oligonucleotide corresponding to the miRNA. A U6 probe was used
as an internal loading control. Band intensity was measured using a
Typhoon phosphoimager and ImageQuant program.
miRNA duplex and LNA-anti-miRNA transfection in ES cells
miR-141, miR-200, miR338, or miR-429 duplexes (Sigma) were
transfected into ES cells at a ﬁnal concentration of 100nM by
DharmaFECT1 (Dharmacon) transfection reagent following the
manufacturer’s instructions. DharmaFECT1 transfection reagent
alone was used as a mock control. Total RNAwas isolated at 12 and
24h post transfection. Transfection of mixed miRNAs duplex and
LNA-anti-miRNAs (50nM, obtained from Exiqon) into ES cells was
carried out by electroporation with Gene Pulser (Bio-Rad) at a
constant voltage of 240mV, 500mF. The sequences of miRNA
duplexes are listed in Supplementary Table S2. As control, the
scrambled miRNA duplexes were designed with two nucleotides
substitutions at the seed sequences of guide strand: AACACU to
ACAACU (miR-141), UAACAC to UAGCGC (miR200a), and UAAUAC
to UCGUAC (miR-429). The LNA-anti-miRNAs were purchased from
Exiqon and the sequences of wild-type LNA-anti-miRNAs were
listed in Supplementary Table S2. A similar design using two
nucleotides substitutions at the seed sequences was achieved for
scrambled LNA-anti-miRNAs: AGTGTT to AGTACT (LNA-anti-
miR141), AGTGTT to AGGGGT (LNA-anti-miR200a), and GTATTA
to GTAGCA (LNA-anti-miR429).
Microarray analysis
Total RNAwas extracted by TRIzol reagent (Invitrogen), puriﬁed by
Qiagen RNeasy kit, and processed for hybridization to custom
Agilent microarrays containing oligonucleotides corresponding to
approximately 21000 genes. Hybridizations were performed with
ﬂuorescent label reversal to eliminate dye bias. Data shown are
signature genes that display a difference in expression level
(Po0.01) relative to mock-transfected cells. Data were analysed
using Rosetta Resolver software. Transcript regulation was calcu-
lated as the error-weighted mean log10 ratio for each transcript
across the ﬂuor-reversed pair. To remove a common signature and
show miRNA-speciﬁc signatures, the expression signatures for each
treatment have been ratioed to the average of all treatments in the
corresponding experiment. Microarray data are available at NCBI’s
Gene Expression Omnibus, Series GSE13127). miRNA target
candidates were deﬁned as those transcripts showing signiﬁcant
downregulation in miRNA-treated cells versus mock-treated cells
(log10 ratio o0 and P-value o0.01). miRNA target candidates
identiﬁed by microarray were examined for sequence complemen-
tarity to the seed region of the miRNA. Each individual hexamer
within the seed region octamer (bases 1–8) was examined. miRNA
target candidates were validated by RT–PCR. Brieﬂy, cDNA was
synthesized by SuperScript II kit (Invitrogen) according to the
manufacturer’s instructions. The transcript expression level was
measured by real-time PCR with SYBR Green detection on
ABI7900HT system (Applied Biosystems). S16 was used as internal
control for normalization (DCt). The expression level (DDCt) was
measured by subtraction of DCt (derived from overexpressing cells)
from the DCt (derived from the vector control). Primers for real-time
PCR are available on request. Transcripts downregulated in MYC-
overexpressing cells were determined as above, relative to empty
lentiviral vector-infected cells.
Western blotting
Total protein was extracted in RIPA buffer 48h post transfection of
individual miR-141, miR-200, or miR-338 duplexes was examined
whether the protein level of miRNA targets also decreased. All
antibodies for western blot were obtained from Santa Cruz
Biotechnology Inc and used according to the manufacturer’s
instructions. Subsequent to selection of ES cell colonies over-
expressing c-Myc as described above, LNA-anti-miRNAs from
Exiqon were introduced into these cells, incubated for 4 days, and
total protein after extraction in RIPA buffer was subjected to
western blot analysis.
Manipulating c-Myc level in ES cells by lentiviral-delivered
shRNA knockdown
shRNA sequences against c-Myc was designed by using Dharmacon
siDESIGN and then hairpin siRNA oligonucleotides were annealed
and cloned into modiﬁed FUGW lentiviral vector with an H1
promoter (Lien et al, 2008)). Lentiviral production followed an
earlier published protocol (Lois et al, 2002), then drug selection for
positive integration in ES cells 3 days after infection. Positive clones
were picked and expanded for differentiation experiments.
miRNA target speciﬁcity by dual luciferase reporter assay
The 30 UTR of Cdh11, Nrp1, and Zfh1a were ampliﬁed by PCR from
ES cells cDNA and cloned into pGL3-control vector (Promega) at the
30 end of the ﬁreﬂy luciferase (FL) gene and then transformed into
damþ Escherichia coli strain. Point mutations within each putative
miRNA target site were made by PCR-based site-directed mutagen-
esis. HeLa cells were plated at 10
4 cells per well in 24-well plates on
the day before transfection. Subsequently, 100nM of miRNA duplexes,
500ng of FL expression construct carrying either wild-type or mutated
developmental genes
involved in differentiation
B-cell lineage differentiation
ES cell self-renewal miR-29
miR-181
c-Myc
miR-141
miR-200
miR-338
miR-429
Self-organizing network maintains ES cells pluripotency
Figure 9 c-Myc is involved in ES cell pluripotency through regula-
tion of miRNAs. The ﬁgure summarizes a putative pathway through
which c-Myc regulates groups of miRNAs in ES cells that in turn
control genes involved in differentiation and self-renewal.
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co-transfected into cells by using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Forty hours later,
a luciferase assay was performed using the ‘Dual Luciferase Reporter
Assay System’ (Promega). The experiments were carried out in four
independent replicates.
FACS analysis
Individual miRNA-duplex-transfected ES cells were cultured on
0.1% gelatin-coated plates. At days 2, 5, 7, or 10 after LIF
withdrawal the cells were collected using trypsin and washed with
PBS before SSEA-1 antibody incubation (Chemicon, mouse mono-
clonal 1:200 dilution) for 2h. Cells were subsequently washed with
PBS twice and incubated with PE-conjugated secondary antibody.
Finally, cells were washed twice and resuspended in PBS before
FACS analysis. The population (%) of positive SSEA-1-stained cells
was compared with unstained cells, PE-isotype control, undiffer-
entiated ES cells, and cells stained with secondary antibody alone.
The two-sample t-test was applied to determine whether the
average difference between miRNA transfection and mock control
was signiﬁcant.
Analysis of AP activity
Individual miRNA or combined miRNA-transfected ES cells were
cultured on 0.1% gelatin-coated chamber slides and cells at days 2,
5, 7, or 10 after LIF withdrawal were ﬁxed with 4% paraformalde-
hyde for 2min before AP activity assay (Chemicon, Alkaline
phosphatase detection kit).
Nanog immunocytochemistry
ES cells cultured on 0.1% gelatin-coated chamber slides were mock
transfected or transfected with miRNA duplexes. At day 5 after LIF
withdrawal, cells were ﬁxed with 4% paraformaldehyde for 10min
before blocking with 10% goat serum in 1 PBS/0.5%Triton X-100.
Subsequently, Nanog antibody (Abcam:ab21603-100) 1:500 dilution
in 1 PBS/0.5%Triton X-100 was used for staining overnight. The
AlexaFlur 594-conjugated secondary was used followed by three
washes with 1 PBS/0.5%Triton X-100. Images were taken using
the Zeiss 510 confocal microscope.
ChIP and DNA microarrays (ChIP–chip)
Cells were crosslinked with 1.1% formaldehyde and then blocked
with 0.125M glycine before lysis and sonication to produce 0.2–
1kb DNA fragments. Protein-A-agarose beads (50% slurry) were
blocked with 2mg/ml sonicated salmon sperm DNA and 0.5mg/ml
BSA and washed twice in lysis/sonication buffer (50mM Tris,
10mM EDTA, 1%SDS, pH¼8) before use. Chromatin was pre-
cleared with control IgG before immunoprecipitation overnight with
c-Myc rabbit polyclonal antibody (Santa Cruz, #SC764, Lot:F1307).
ChIP and ampliﬁcation (ligation-mediated PCR) for ChIP–chip
analysis followed NimbleGen protocol. Custom-designed DNA
microarrays including miR124, miR135a, miR135b, miR-141, miR-
200, miR302, miR338, and miR-429 were tiled through 3kb
upstream and downstream of miRNA transcripts with isothermal
probes. For endogenous Myc binding, triplicate sets of ChIP and
input DNA were applied on this custom array and genomic sites
enriched for c-Myc binding were calculated by ChIP versus input
(log2 ratio provided by NimbleGen data output). We used both log2
ratios from ChIP/input normalization and P-values from computer
program ACME (window¼500 nucleotides, threshold¼0.95)
(Scacheri et al, 2006a,b) to identify promoter regions signiﬁcantly
enriched for c-Myc binding (Po0/0001). c-Myc overexpression in
ES cells by lentiviral delivery was performed as described earlier
and triplicate sets of ChIP and input DNA were hybridized on
this custom array. The ChIP–chip enrichment ratio was calculated
and analysed as described above for endogenous Myc binding.
To validate the ChIP–chip data, 1ng input and ChIP DNA from
independent sets of ChIP were applied to quantitative real-time PCR
(qRT–PCR) by using SYBR green PCR mix (Applied Biosystems)
on ABI7900HT detection system. The enrichment was calculated as
% input as described (Frank et al, 2001). We evaluated enrichment
from duplicates of two independent ChIPassays obtained from both
the R1 and AK7 ES cell lines. The sequences of all primers for
qChIP–PCR were based on the Myc binding (100–200bp to miRNA
coding regions) identiﬁed from ChIP–chip analysis (sequences are
available on request).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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